Recent Development in Nanomedicine on the Use of Amygdalin in the Prevention and Treatment of Cancer: A Bibliometric Analysis

Cancer is a serious health problem and one of the leading causes of death in humans in both developing and underdeveloped countries. Researchers are using nanotechnology to improve the specificity and effectiveness of cancer therapy as the number of cancer cases worldwide increases daily. The aim of this bibliometric analysis is to examine current advances in nanomedicine based on existing scientific work on the use of amygdalin in cancer research. Bibliometric analysis was performed with VOSviewer software using the Scopus database. Out of 439 articles in the literature, 149 were found for bibliometric analysis, 11 of which were about nanomedicine and were recently published. China was the most productive country in this field, with Tabriz University being the leading research organization. The journals that published the most articles on this topic were Anti-Cancer Agents in Medicinal Chemistry and Molecular Biology Reports. The most frequently occurring keywords in these clusters were “cancer”,” “tumour” and “amygdalin.” This work provides a summary of the literature with a graphical representation of the research on the development of amygdalin through a bibliographic analysis. In addition, this study offers a new perspective that could serve as a guide for future research directions.